An esketamine clinic is a certified healthcare facility that administers esketamine treatment to eligible patients with treatment-resistant depression (TRD) and certain adults with Major Depressive Disorder (MDD). Esketamine, marketed under the brand name Spravato®, is available only through a specialized safety program known as the Risk Evaluation and Mitigation Strategy (REMS), which requires treatment to be administered under direct medical supervision in certified healthcare settings.
Esketamine clinics are staffed by qualified mental health professionals who evaluate patients, administer treatment, monitor safety, and provide ongoing support throughout the treatment process.
Before treatment begins, patients undergo a comprehensive psychiatric evaluation to determine whether esketamine treatment is appropriate. If a patient qualifies, the treatment team develops an individualized care plan based on the patient’s symptoms, diagnosis, treatment history, and goals.
During treatment at an esketamine clinic:
Because esketamine may cause sedation, dissociation, and temporary increases in blood pressure, patients are monitored for at least two hours following treatment.
Treatment at an esketamine clinic may be appropriate for individuals who:
A comprehensive psychiatric assessment is necessary to determine treatment eligibility.
Choosing the right esketamine clinic is an important part of successful treatment.
Esketamine clinics must participate in the SPRAVATO REMS program and follow established safety requirements for administering treatment.
Look for clinics staffed by experienced psychiatrists and psychiatric providers familiar with treatment-resistant depression and advanced mental health therapies.
Clinics offering psychotherapy, medication management, and additional treatment options can provide more integrated care.
Quality clinics perform detailed evaluations and develop personalized treatment plans tailored to each patient’s unique needs.
Because esketamine treatment requires observation after each session, clinics should provide a safe, supportive, and closely monitored treatment environment.
Receiving treatment at a certified esketamine clinic may provide several benefits, including:
Many patients receive esketamine treatment alongside psychotherapy, medication management, or other evidence-based mental health interventions.
At Pinnacle Behavioral Healthcare, our experienced psychiatric team provides comprehensive evaluations to determine whether Spravato Therapy is appropriate for each patient’s needs. We develop individualized treatment plans designed to help patients achieve meaningful improvements in their mental health and overall well-being.
In addition to Spravato therapy, we offer Medication Management, Individual Psychotherapy, and Pinnacle TMS as part of our comprehensive mental healthcare services.
If traditional depression treatments have not provided sufficient relief, schedule a consultation with our team to discuss whether esketamine treatment may be right for you.
An esketamine clinic is a certified healthcare facility that administers esketamine treatment, such as Spravato®, under medical supervision for eligible patients with treatment-resistant depression.
No. Esketamine treatment must be administered in a certified healthcare setting under direct medical supervision as required by the SPRAVATO REMS program.
Patients are typically monitored for at least two hours after treatment to ensure safety and evaluate for side effects.
A psychiatric provider will review your symptoms, treatment history, medical history, and current medications to determine whether esketamine treatment is appropriate for you.
Yes. Many esketamine clinics also offer psychotherapy, medication management, psychiatric evaluations, TMS therapy, and other comprehensive mental health services.
